The feasibility of nitric oxide delivery with high frequency jet ventilation.
A 27-year-old female with acute monocytic leukaemia (M5) developed acute respiratory distress syndrome (ARDS). Because of refractory hypoxaemia and severe barotrauma during conventional mechanical ventilation, the patient was switched to high frequency jet ventilation (HFJV) as a salvage therapy. Her refractory hypoxaemia improved temporarily but worsened again. Approval of the Institutional Review Board and the Food and Drug Administration was obtained to use nitric oxide (NO) with HFJV on a compassionate basis considering the grave situation. The NO delivery system was connected to the secondary flow circuit of the HFJV immediately after the humidifier. We measured the concentration of NO at least every hour by inserting a 7-Fr catheter connected to a McNeill analyzer into the endotracheal tube. Despite improvement of oxygenation, the patient's respiratory status deteriorated further and she died. In this case we were able to achieve reliable and constant levels of NO. The purpose of this report is to discuss the technical aspects and pitfalls of this method.
Arabi
Yaseen
Y
Department of Intensive Care, King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia. arabi@ngha.med.sa
Kumar
Anand
A
Wood
Kenneth
K
Flaten
Anne
A
D000328:Adult; D017809:Fatal Outcome; D005260:Female; D006611:High-Frequency Jet Ventilation; D006801:Humans; D007948:Leukemia, Monocytic, Acute / Q000150:complications; D009569:Nitric Oxide / Q000008:administration & dosage*; D012128:Respiratory Distress Syndrome / Q000209:etiology / Q000628:therapy*
D009569:Nitric Oxide